Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents
Moreover, increased 11-HSD1 activity has been demonstrated in SAT in subjects with obesity [143, 145], and correlated with the degree of obesity and IR [145, 146]
Although results of studies in animal models have been promising (reviewed in 128), it is not yet known whether DHA supplementation can help treat Alzheimer's disease in humans
The most frequently reported BPC-157 side effects are injection site reactions (redness, mild swelling, temporary stinging) in 15-25% of users
[DOI] [PMC free article] [PubMed] [Google Scholar] 42.Newsome P.N., Buchholtz K., Cusi K., Linder M., Okanoue T., Ratziu V., Sanyal A.J., Sejling A.S., Harrison S.A., NN9931-4296 Investigators A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis